Health
Research reveals underperformance of many Phase III oncology trials – News-Medical.Net
New research in the September 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that more than…
New research in the September 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that more than 80% of therapies tested in Phase III oncology trials did not achieve meaningful clinical benefit in prolonging survival. The researchers…
Continue Reading
-
General10 hours agoDreams shattered as 140 Zone RV caravan customers’ worst fears realised
-
Noosa News20 hours agoCollapsed Queensland caravan maker Zone RV accused of trading insolvent
-
General12 hours agoHow the Bondi shooters got access to now-banned guns
-
General12 hours agoPublisher ditches David Walliams after harassment claim